Navigation Links
WallSt.net (www.wallst.net) Updates the Investment Community Through All-New Interviews With XMDC, POSS and TYPE
Date:10/18/2007

NEW YORK, Oct. 18 /PRNewswire/ -- On October 2, Paul Lisenby, Chairman and CEO of XTend Medical Corp. (Pink Sheets: XMDC) updated the investment community in an all-new interview with http://www.wallst.net. Interview highlights include detailed discussions on the following topics:

-- focus on creating medical technologies for the diabetes market

-- demographic trends bolstering the company's growth prospects

-- management bios

-- how strategic partnerships play a role in the company's growth

-- reasons the company's solutions have a competitive edge

-- upcoming milestones for investors to watch for

To hear the interview in its entirety, and to read an in-depth report on the company, visit http://www.wallst.net/superstocks/superstocks_profile.asp?ticker=xmdc

On October 5, Jules Fisher, Chief Financial Officer for Possis Medical, Inc. (Nasdaq: POSS) (http://www.possis.com) updated the investment community in an all-new interview with http://www.wallst.net. Interview highlights include detailed discussions on the following topics:

-- how the company was able to offset the decline from its coronary

business

-- moving into a "recovery mode"

-- reasons the company is "behaving like a growth company again"

-- market opportunities for the company's medical technology solutions

-- upcoming milestones for investors to watch for

To hear the interview in its entirety, visit http://www.wallst.net/audio/audio.asp?ticker=POSS&id=3977

On October 4, Douglas Shaw, CEO of Monotype Imaging Holdings, Inc. (Nasdaq: TYPE) (http://www.monotypeimaging.com) updated the investment community in an all-new interview with http://www.wallst.net. Interview highlights include detailed discussions on the following topics:

-- how the company combines technology and typefaces

-- applications for the company text imaging solutions

-- distribution channels for licensing business

-- industry trends bolstering the company's growth prospects

-- upcoming milestones for investors to watch for

To hear the interview in its entirety, visit http://www.wallst.net/audio/audio.asp?ticker=TYPE&id=3962

About WallSt.net:

http://www.wallst.net is owned and operated by WallStreet Direct, Inc., a wholly owned subsidiary of Financial Media Group, Inc. (http://www.financialmediagroupinc.com). The Web site is a leading provider of timely business news, executive interviews, multimedia content and research tools. Financial Media Group, Inc. also owns http://www.mywallst.net, a financial social network for investors, and Financial Filings Corp. (http://www.financialfilings.com), a provider of media and compliance solutions to publicly traded companies. In addition to WallSt.net, WallStreet Direct, Inc. owns and operates WallStRadio (http://www.wallstradio.com), a business and finance podcast Web site. We have received one million two hundred fifty thousand restricted shares of XMDC from XTend Medical Corp. for media and advertising services. For a complete list of our advertisers, and advertising relationships, visit http://www.wallst.net/disclaimer/disclaimer.asp.

(Logo: http://www.newscom.com/cgi-bin/prnh/20050927/LATU121LOGO)

CONTACT:

WallSt.net

800-4-WALLST


'/>"/>
SOURCE WallStreet Direct, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. WHO Updates Outdated Pediatric Growth Charts
2. China Doubles Its Investment In AIDS/HIV Treatment.
3. Biocon To Raise Its Investment In Scotland
4. Cocoa Treats: Chocolates, as a Health Investment? Chew on this!
5. Varicose Vein Treatments Turn Out To Be A Viable Health Investment
6. WHO calls for big investment in tests for TB
7. China Opens Doors For Foreign Investments In Hospitals Care System
8. Fidel Castro Appeals for Investment in Health Rather Than in Arms
9. International community warns India on HIV situation
10. Medical community worried that new curriculum will Promote Quackery
11. Wangaratta Community fundraising for Herceptin drug
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/13/2017)... ... 2017 , ... Global Healthcare Management’s 4th Annual Kids Fun Run brought out ... free event, sponsored by Global Healthcare Management’s CEO, Jon Letko, is aimed at getting ... children of all ages; it is a non-competitive, non-timed event, which is all about ...
(Date:10/13/2017)... ... October 13, 2017 , ... “America On The Brink”: the Christian ... On The Brink” is the creation of published author, William Nowers. Captain Nowers ... a WWII veteran, he spent thirty years in the Navy. Following his career ...
(Date:10/12/2017)... CITY, Fla. (PRWEB) , ... October 12, 2017 , ... ... cold therapy products, announced today the introduction of an innovative new design of the ... multipurpose pad so you get maximum comfort while controlling your pain while using cold ...
(Date:10/12/2017)... ... 12, 2017 , ... HMP , a leader in healthcare events and ... Eddie Digital Award for ‘Best B-to-B Healthcare Website.’ Winners were announced during the Eddie ... annual award competition recognizes editorial and design excellence across a range of sectors. This ...
(Date:10/12/2017)... ... October 12, 2017 , ... In the ... a year. In some states—like New York, New Jersey, Massachusetts, Texas, Virginia, Connecticut, ... retirement havens have extremely low property-tax rates, which contributes to the relatively lower ...
Breaking Medicine News(10 mins):
(Date:9/28/2017)... CHICAGO , Sept. 28, 2017 Hill-Rom ... quarter 2017 earnings conference call and webcast on Friday, ... 8:00 a.m. (EDT) and ending at approximately 8:30 a.m. ... to discussing the company,s 2017 financial performance and guidance ... growth opportunities, initiatives to enhance operational performance, and long-range ...
(Date:9/27/2017)... and NEW YORK , Sept. 27, 2017  DarioHealth ... and big data solutions, today announced that its MyDario product is expected ... local TV listings for when The Dr. Oz Show airs in your ... The nine-time Emmy ... ...
(Date:9/23/2017)... 2017 Janssen Biotech, Inc. (Janssen) announced today ... the U.S. Food and Drug Administration (FDA) for the ... the treatment of moderately to severely active rheumatoid arthritis ... are needed to further evaluate the safety of sirukumab ... "We are ...
Breaking Medicine Technology: